What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

% Price Oscillator

Score

1.0

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 7 50.7 0.43% 0.75% 139.3% -6.6% 391.8%
SHORT 8 59.8 0.50% 1.00% 77.7% -3.1% 298.7%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

% PRICE OSCILLATOR


Last Signal:

BEARISH


Trading: SELL @ $2.67
Signal Strength: STRONG
Recommendation:

Opthea (ASX:OPT) currently has negative PPO -3.511%. This means the current price is losing momentum through a fall on the short term exponential moving average.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement


The Percentage Price Oscillator (PPO) is a momentum oscillator that measures the difference between two moving averages as a percentage of the larger moving average.

Calculation: Percentage Price Oscillator (PPO):
1) PPO Line: {(12-day EMA - 26-day EMA)/26-day EMA} x 100;
2) Signal Line: 9-day EMA of PPO;
3) Histogram: PPO - Signal Line;


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

% Price Oscillator

Download
Company Close Change(%) Volume Value Signal
ISD Isentia 0.26 8.3 518,734 4.31 BULLISH
PTM Platinum Asset Management 4.55 7.6 1,696,244 0.44 BULLISH
IMF IMF 3.81 6.7 2,751,384 0.7 BULLISH
BSL Bluescope Steel 15.21 5.2 2,787,185 0.23 BULLISH
RWC Reliance Worldwide Corporation 4.18 4.8 2,029,284 2.26 BULLISH
PPH Pan Pharmaceuticals 3.93 4.5 41,736 0.82 BULLISH
BFG Bell Financial 1.15 4.5 338,716 2.04 BULLISH
MND Monadelphous 17.47 4.5 518,378 2.97 BULLISH
GRR Grange Resources 0.24 4.3 393,189 1.09 BULLISH
BSA Broadcast Services Australia 0.4 3.9 307,029 3.46 BULLISH